Part of the Public Health Service Act of 1992, the 340B Drug Pricing Program lowers drug costs and increases revenues for safety-net health care providers by allowing them to pay heavily discounted prices for prescription ...
Jan 16, 2024
0
0
About one in 10 prescription drugs—mainly brand-name and expensive drugs and those for rare diseases—has a manufacturer-sponsored patient support program, which usually includes financial, nursing and educational supports.
Nov 27, 2023
0
0
Three out of four American adults say prescription drug prices are unaffordable, and nearly a third admit to not taking prescribed medications due to cost, according to a recent poll conducted by the Kaiser Family Foundation. ...
Oct 10, 2023
0
1
Swiss generic drugs group Sandoz began trading as an independent company in Zurich on Wednesday, in a stock market debut following a spin-off by parent company Novartis as it pivots toward new drug development.
Oct 4, 2023
0
12
Civica Rx, a not-for profit drug manufacturer founded by seven US health systems and three philanthropic organizations, increased supply security and lowered cost on aggregate for 20 drug products, according to the first ...
Sep 20, 2023
0
9
The U.S. biosimilar drug market emerged in 2015 to provide safe, effective, and more affordable alternatives to existing biologic drugs, but it has been slow to develop compared with Europe.
Jun 6, 2023
0
1
Unhealthy food dominated the weekly grocery store flyers. As much as two thirds of the space was taken up by less healthy foods according to a study from the University of Gothenburg. The advertising does not seem to support ...
May 31, 2023
0
10
In January 2021, the Centers for Medicare and Medicaid Services (CMS) passed a federal law that requires hospitals to make the costs of standard healthcare services transparent. Investigators at the Brigham systematically ...
Feb 8, 2023
0
3
More biosimilars have been marketed in Germany and Switzerland than in the United States, but uptake has increased over time in all countries, according to a study published online Dec. 2 in JAMA Network Open.
Dec 2, 2022
0
3
High fixed costs for retailing fresh fruit and vegetables means that they cost 40% more than would be efficient, unlike unhealthy alternatives, which trade close to marginal cost, a new study demonstrates.
Mar 30, 2022
7
46
